Bristol-Myers Squibb
Last updated on 2015-01-03T21:55+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| specialist | 2.44% | EN | 10/10/2017 |
| rival | 26.83% | EN | 16/02/2017 |
| leader | 63.41% | EN | 31/07/2016 |
| chief executive officer | 2.44% | EN | 31/01/2012 |
| rival | 4.88% | PT | 22/03/2006 |
| Names | Lang | Count |
|---|---|---|
| Bristol-Myers Squibb | EN | 61.87% |
| Bristol-Myers Squibb | FR | 9.18% |
| Bristol Myers Squibb | EN | 4.38% |
| Bristol-Myers Squibb | PT | 2.70% |
| Bristol-Myers Squibb | ES | 2.22% |
| Bristol-Myers Squibb | DE | 2.16% |
| Bristol-Myers Squibb | IT | 2.01% |
| Bristol-Myers Squibb | PL | 2.01% |
| Bristol-Myers Squibb | HR | 1.98% |
| Bristol-Myers Squibb | SV | 1.98% |
| Bristol-Myers Squibb | EU | 1.98% |
| Bristol-Myers Squibb | ZH | 1.98% |
| Bristol Myers Squibb | FR | 0.97% |
| Bristol Myers-Squibb | EN | 0.88% |
| Bristol-Meyers Squibb | EN | 0.73% |
| Bristol Myers Squibb | ES | 0.55% |
| Bristol Myers Squibb | RO | 0.52% |
| Bristol-Meyers Squibb | FR | 0.27% |
| Bristol Meyers Squibb | EN | 0.24% |
| Bristol Myers-Squibb | DE | 0.21% |
| Bristol Myers-Squibb | FR | 0.21% |
| Bristol Myers Squibb | PT | 0.21% |
| BRISTOL-MYERS SQUIBB | FR | 0.18% |
| BRISTOL MYERS SQUIBB | FR | 0.12% |
| Bristol-Myers-Squibb | EN | 0.12% |
| Bristol-Myers-Squibb | FR | 0.09% |
| BRISTOL-Myers Squibb | FR | 0.03% |
| Bristol-Myers-Squibb | EU | 0.03% |
| Bristol Meyers Squibb | FR | 0.03% |
| Bristol Myers Squibb | DE | 0.03% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 5.93% |
| Pfizer Inc | 2.70% |
| Novartis | 2.29% |
 | Francis Collins | 1.77% |
| S government | 1.77% |
| Donald Trump | 1.56% |
| Wall Street | 1.46% |
| Dow Jones | 1.46% |
| GlaxoSmithKline | 1.46% |
| Commission | 1.35% |
| Eli Lilly | 1.35% |
| Health Ministry | 1.25% |
| Roche Holding AG | 1.14% |
| Pharmaceuticals Inc | 1.14% |
| British | 1.14% |
| Roselyne Bachelot | 1.04% |
| Van Laethem | 1.04% |
| Viktor Orban | 1.04% |
| Robert Koch Institute | 1.04% |
| BERLIN | 1.04% |
| Bertrand Levrat | 1.04% |
| Geneva University | 1.04% |
| Yves Van | 1.04% |
| Alexander De Croo | 1.04% |
| Joseph Biden | 0.94% |
| Czech military | 0.94% |
| British Broadcasting Corporation | 0.94% |
| Jeremy Farrar | 0.94% |
| RTL radio | 0.94% |
| European Union | 0.94% |
| Type | Entity Name | Score |
|---|---|---|
| Novartis | 0.0234 |
| Pfizer Inc | 0.0219 |
| Francis Collins | 0.0149 |
| GlaxoSmithKline | 0.0146 |
| Inc | 0.0138 |
| Eli Lilly | 0.0133 |
| Bertrand Levrat | 0.0127 |
| Pharmaceuticals Inc | 0.0118 |
| Roche Holding AG | 0.0112 |
| Geneva University | 0.0112 |
| Dow Jones | 0.0103 |
| Roselyne Bachelot | 0.0101 |
| Van Laethem | 0.0101 |
| Yves Van | 0.0101 |
| S government | 0.0099 |
| Eric van den Berg | 0.0094 |
| Alexander De Croo | 0.0092 |
| RTL radio | 0.0091 |
| Jeremy Farrar | 0.0089 |
| Viktor Orban | 0.0087 |
| Gregory Frost | 0.0087 |
| Boehringer Ingelheim | 0.0083 |
| Robert Koch Institute | 0.0082 |
| Czech military | 0.008 |
| Hang Seng | 0.0079 |
| Nikkei 225 | 0.0079 |
| Wall Street | 0.0078 |
| Karen Hoguet | 0.0077 |
| Research Development | 0.0073 |
| Bakir Izetbegovic | 0.007 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Sunday, October 25, 2020
1:51:00 PM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 